Decoy Therapeutics Inc (DCOY)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 10,710 | 2,435 | 5,900 | 12,106 | 29,214 |
| Receivables | N/A | N/A | N/A | 1,611 | N/A |
| TOTAL | $10,985 | $2,988 | $6,520 | $14,520 | $30,164 |
| Non-Current Assets | |||||
| PPE Net | 41 | N/A | N/A | N/A | N/A |
| Intangibles | 0 | 0 | 0 | 0 | 8,866 |
| Other Non-Current Assets | 31 | 35 | 67 | 131 | 1,804 |
| TOTAL | $72 | $35 | $67 | $131 | $10,670 |
| Total Assets | $11,057 | $3,023 | $6,587 | $14,651 | $40,834 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,080 | 937 | 603 | 2,858 | 1,543 |
| Accrued Expenses | 859 | 352 | 407 | 1,408 | 568 |
| Other current liabilities | 2 | N/A | N/A | N/A | N/A |
| TOTAL | $5,168 | $1,511 | $1,299 | $4,266 | $2,111 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,226 | N/A | N/A | N/A | N/A |
| TOTAL | $N/A | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $5,168 | $1,511 | $1,299 | $4,266 | $2,111 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 532 | 10 | 3 | 2 | 1 |
| Retained earnings | -94,442 | -81,924 | -76,348 | -63,805 | -32,197 |
| TOTAL | $5,889 | $1,512 | $5,287 | $10,385 | $38,723 |
| Total Liabilities And Equity | $11,057 | $3,023 | $6,587 | $14,651 | $40,834 |